These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of four coagulation tests to detect plasma lupus anticoagulants. Saxena R; Saraya AK; Kotte VK; Singh YN; Prasad L; Malviya AN Am J Clin Pathol; 1991 Dec; 96(6):755-8. PubMed ID: 1746492 [TBL] [Abstract][Full Text] [Related]
3. Lupus anticoagulant testing: effect of the platelet count on the activated partial thromboplastin time. Brien WF; Schaus MR; Cooper KE; O'Keefe BT; Inwood M Br J Biomed Sci; 1993 Jun; 50(2):114-6. PubMed ID: 8219916 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of a new commercial dilute prothrombin time in the diagnosis of lupus anticoagulants. Devreese KM Thromb Res; 2008; 123(2):404-11. PubMed ID: 18495217 [No Abstract] [Full Text] [Related]
6. Laboratory testing for lupus anticoagulant (LA) in patients taking direct oral anticoagulants (DOACs): potential for false positives and false negatives. Favaloro EJ; Mohammed S; Curnow J; Pasalic L Pathology; 2019 Apr; 51(3):292-300. PubMed ID: 30665674 [TBL] [Abstract][Full Text] [Related]
7. Clinical and laboratory characteristics of isolated lupus anticoagulants. Mattia E; Tonello M; Del Ross T; Zerbinati P; Campello E; Simioni P; Ruffatti A Thromb Res; 2018 May; 165():51-53. PubMed ID: 29567587 [No Abstract] [Full Text] [Related]
8. Guidelines on testing for the lupus anticoagulant. Lupus Anticoagulant Working Party on behalf of the BCSH Haemostasis and Thrombosis Task Force. J Clin Pathol; 1991 Nov; 44(11):885-9. PubMed ID: 1752976 [No Abstract] [Full Text] [Related]
9. Dilute Russell's viper venom and activated partial thromboplastin time in lupus anticoagulant diagnosis: is mixing essential? Chandrashekar V Blood Coagul Fibrinolysis; 2016 Jun; 27(4):408-11. PubMed ID: 26626041 [TBL] [Abstract][Full Text] [Related]
10. The laboratory heterogeneity of lupus anticoagulants. Triplett DA; Brandt JT; Maas RL Arch Pathol Lab Med; 1985 Oct; 109(10):946-51. PubMed ID: 3929747 [TBL] [Abstract][Full Text] [Related]
13. A report on the First International Workshop for Lupus Anticoagulant Identification. Barna LK; Triplett DA Clin Exp Rheumatol; 1991; 9(6):557-67. PubMed ID: 1684920 [TBL] [Abstract][Full Text] [Related]
14. Lupus-anticoagulant testing at NOAC trough levels. Ratzinger F; Lang M; Belik S; Jilma-Stohlawetz P; Schmetterer KG; Haslacher H; Perkmann T; Quehenberger P Thromb Haemost; 2016 Aug; 116(2):235-40. PubMed ID: 27075441 [TBL] [Abstract][Full Text] [Related]
16. Effect of instruments on lupus anticoagulant testing. Exner T; Hohnen-Behrens C; Newman P; Dargan W Thromb Haemost; 2000 Feb; 83(2):345-8. PubMed ID: 10739397 [No Abstract] [Full Text] [Related]
17. Fatal bleeding in a patient with a non-specific PT and APTT inhibitor. Krikler SH; Carter CJ; Chonn A; Levitt D; Devine DV Clin Lab Haematol; 1992; 14(1):73-9. PubMed ID: 1600696 [No Abstract] [Full Text] [Related]
18. False positive lupus anticoagulant tests in patients with high C-reactive protein: A comparison of two hexagonal phase reagents. Mize R; Mueller S; Roth M; Montgomery G; Battinelli EM; Uljon S Int J Lab Hematol; 2024 Apr; 46(2):411-414. PubMed ID: 38185483 [No Abstract] [Full Text] [Related]
19. Effects of direct oral anticoagulants on lupus anticoagulant assays in a real-life setting. Antovic A; Norberg EM; Berndtsson M; Rasmuson A; Malmström RE; Skeppholm M; Antovic J Thromb Haemost; 2017 Aug; 117(9):1700-1704. PubMed ID: 28640321 [TBL] [Abstract][Full Text] [Related]